Chow KC - Search Results

1

Expression of 53BP1 as a cisplatin-resistant marker in patients with lung adenocarcinomas.

Lai TC, Chow KC, Lin TY, Chiang IP, Fang HY, Chen CY, Ho SP. Lai TC, et al. Among authors: chow kc. Oncol Rep. 2010 Aug;24(2):321-8. doi: 10.3892/or_00000862. Oncol Rep. 2010. PMID: 20596616

2

Expression of Fas ligand in patients with evident skull base involvement of nasopharyngeal carcinoma.

Tsai MH, Chow KC, Lin TY, Yeh SP, Hsueh CT, Chi KH. Tsai MH, et al. Among authors: chow kc. Oncol Rep. 2002 Mar-Apr;9(2):247-51. Oncol Rep. 2002. PMID: 11836588

3

Expression of dihydrodiol dehydrogenase in the resected stage I non-small cell lung cancer.

Chen CY, Hsu CP, Hsu NY, Shih CS, Lin TY, Chow KC. Chen CY, et al. Among authors: chow kc. Oncol Rep. 2002 May-Jun;9(3):515-9. Oncol Rep. 2002. PMID: 11956619

4

Reduction of dihydrodiol dehydrogenase expression in resected hepatocellular carcinoma.

Yang MD, Wu CC, Chiou SH, Chiu CF, Lin TY, Chiang IP, Chow KC. Yang MD, et al. Among authors: chow kc. Oncol Rep. 2003 Mar-Apr;10(2):271-6. Oncol Rep. 2003. PMID: 12579257

5

Prognostic significance of expression of nm23-H1 and focal adhesion kinase in non-small cell lung cancer.

Hsu NY, Chen CY, Hsu CP, Lin TY, Chou MC, Chiou SH, Chow KC. Hsu NY, et al. Among authors: chow kc. Oncol Rep. 2007 Jul;18(1):81-5. Oncol Rep. 2007. PMID: 17549350

6

Expression of rTSbeta as a 5-fluorouracil resistance marker in patients with primary breast cancer.

Kuo SJ, Wang HC, Chow KC, Chiou SH, Chiang SF, Lin TY, Chiang IP, Chen DR. Kuo SJ, et al. Among authors: chow kc. Oncol Rep. 2008 Apr;19(4):881-8. Oncol Rep. 2008. PMID: 18357371

7

Nuclear expression of dynamin-related protein 1 in lung adenocarcinomas.

Chiang YY, Chen SL, Hsiao YT, Huang CH, Lin TY, Chiang IP, Hsu WH, Chow KC. Chiang YY, et al. Among authors: chow kc. Mod Pathol. 2009 Sep;22(9):1139-50. doi: 10.1038/modpathol.2009.83. Epub 2009 Jun 12. Mod Pathol. 2009. PMID: 19525928 Free article.

8

Expression of xeroderma pigmentosum complementation group C protein predicts cisplatin resistance in lung adenocarcinoma patients.

Lai TC, Chow KC, Fang HY, Cho HC, Chen CY, Lin TY, Chiang IP, Ho SP. Lai TC, et al. Among authors: chow kc. Oncol Rep. 2011 May;25(5):1243-51. doi: 10.3892/or.2011.1184. Epub 2011 Feb 14. Oncol Rep. 2011. PMID: 21327329

9

Caspase-14 is an anti-apoptotic protein targeting apoptosis-inducing factor in lung adenocarcinomas.

Fang HY, Chen CY, Hung MF, Hsiao YT, Chiang TC, Lin TY, Chang HW, Chow KC, Ko WJ. Fang HY, et al. Among authors: chow kc. Oncol Rep. 2011 Aug;26(2):359-69. doi: 10.3892/or.2011.1292. Epub 2011 Apr 29. Oncol Rep. 2011. PMID: 21567094

10

Overexpression of optic atrophy 1 protein increases cisplatin resistance via inactivation of caspase-dependent apoptosis in lung adenocarcinoma cells.

Fang HY, Chen CY, Chiou SH, Wang YT, Lin TY, Chang HW, Chiang IP, Lan KJ, Chow KC. Fang HY, et al. Among authors: chow kc. Hum Pathol. 2012 Jan;43(1):105-14. doi: 10.1016/j.humpath.2011.04.012. Epub 2011 Jul 27. Hum Pathol. 2012. PMID: 21798574

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

187 results

Search Page

Filters